openPR Logo
Press release

Vulva Cancer Market Headed for Growth and Global Expansion by 2025

12-06-2017 12:41 PM CET | Health & Medicine

Press release from: Transparency Market Research

Vulva Cancer Market Headed for Growth and Global Expansion

Vulva cancer is rare type of cancer which forms in a woman’s external genitalia called the vulva. The vulva is an area of the skin that surrounds the vagina and urethra, including mons pubis, perineum, labia, bartholin glands, and clitoris. The labia majora is the most common site to develop vulva cancer. The cancer can occur at any age but primarily affects older women over the age of 65 years. Symptoms of the cancer include pain, itching, bleeding in between menstruation cycle, and tenderness. It often forms lump or sore. Women who are infected with human papillomavirus (HPV) are at a higher risk of developing vulva cancer. Although the most common cause is viral infection, but factors such as smoking, diabetes, hypertension, immune system deficiency, lichen sclerosus, and presence of precancerous conditions such as vulvar intraepithelial neoplasia, increase the risk of vulva cancer. Vulva cancer is the fourth most common gynecologic cancer comprising of 4.7% of malignant neoplasms in the genital tract.

Report Overview and TOC @ https://www.transparencymarketresearch.com/vulva-cancer-market.html

Based on predisposing factor, the vulva cancer market is segmented as human papillomavirus-associated vulva cancer and human papillomavirus unassociated vulva cancer. The human papillomavirus-associated vulva cancer segment is expected to grow as 50%-75% of vulva cancer cases are due to human papillomavirus infection. Based on type, the market is classified as squamous cell carcinoma, adenocarcinoma, basal cell carcinoma, vulvar melanoma, and vulvar sarcoma. The squamous cell carcinoma segment is projected to grow as 95% of the vulvar cancer are squamous cell carcinoma, followed by melanoma and sarcoma. Based on treatment, the market is segmented as surgery, radiation, and chemotherapy. The surgery segment includes laser surgery, vulvectomy, pelvic exenteration, and excision.

Request brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26603

The chemotherapy segment involves the use of drugs that kill and control the growth of cancerous cell. Chemotherapy may also include monotherapy or a combination of two or more drugs depending upon the type of cancer and rate of progression. The chemotherapy segment is expected to grow due to the development of new molecules such as nivolumab by Bristol-Myers Squibb Company for the treatment of vulva cancer. Increase in incidence rate, development of new therapies such as biologics, burden of human papillomavirus infection in women, increase in incidence of sexually transmitted diseases, and less surveillance rate are the factors boosting the growth of the vulva cancer market. However, high cost of therapy and side effects associated with it are factors hampering the growth of the vulva cancer market.

for Specific and Customized requirements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=26603

Geographically, the vulva cancer market is dominated by North America, followed by Europe, due to increase in incidence rate, rise in geriatric population, and growth in research and development expenditure. Asia Pacific is an emerging market due to the developing health care infrastructure, increase in incidence rate, and rising government expenditure in the health care industry. Factors such as rising awareness about vulva cancer and improving economy are driving the vulva cancer market in Middle East & Africa. However, high cost of therapy and lack of proper treatment are restraining the growth of the Middle East & Africa market.

Key players operating in the vulva cancer market include ISA Pharmaceuticals B.V., Ono Pharmaceutical Co., Ltd., ORYX GmbH & Co. KG, F. Hoffmann-La Roche Ltd, Celgene Corporation, Bristol-Myers Squibb Company, Johnson & Johnson, PDS Biotechnology Corporation, Novartis AG, Merck & Co., Pfizer Inc., and Amgen Inc.

Pre Book full report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=26852<ype=S

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact

Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
TMR Blog: http://www.theglobalhealthnews.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vulva Cancer Market Headed for Growth and Global Expansion by 2025 here

News-ID: 847952 • Views: 130

More Releases from Transparency Market Research

Magnetic Field Sensors Market Research Analysis By Basic Information, Manufactur …
Overview: TMR’s report on the Magnetic Field Sensors Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further, undertake strategic planning for the launch of products and services. The Magnetic Field Sensors Market is likely to show an optimistic CAGR of ~8.30% within a forecast period 2015 - 2021. It is expected to reach US$3.5 bn by the forecast period 2015 - 2021. Our research
Solid State Drive Market Growth Trends, Size, Share, Opportunities, Revenue, Reg …
Overview: TMR’s report on the Solid State Drive Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further, undertake strategic planning for the launch of products and services. The Solid State Drive Market is likely to show an optimistic CAGR of ~40.70% within a forecast period 2015 - 2022. It is expected to reach US$229.4 bn by the forecast period 2015 - 2022. Our research
Commercial Refrigerators Market : High Growth Opportunities | Emerging Trends | …
Overview: TMR’s report on the Commercial Refrigerators Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further, undertake strategic planning for the launch of products and services. The Commercial Refrigerators Market is likely to show an optimistic CAGR of ~9.80% within a forecast period 2016 - 2024. It is expected to reach US$38.83 bn by the forecast period 2016 - 2024. Our research report on
PON Equipment Market Current Trends, Swot Analysis, Strategies, Industry Challen …
Overview: TMR’s report on the PON Equipment Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further, undertake strategic planning for the launch of products and services. The PON Equipment Market is likely to show an optimistic CAGR of ~21.00% within a forecast period 2014 - 2020. It is expected to reach USD 1,175.5 million by the forecast period 2014 - 2020. Our research report

All 5 Releases


More Releases for Vulva

Ongoing Forecast Study on Vulvar Cancer Treatment Market to Reveal Key Insights …
Vulvar Cancer is a rare type of cancer in which cancer cells form in the tissues of a vulva. It mostly affects the organs of external genital which protect a reproductive system of a woman. The risk of vulvar cancer mostly affected by vulvar cervical dysplasia and human papillomavirus infection. When cancer originates in the vulva, called primary vulvar cancer; if it spreads another part of the body it is
Vulva Cancer Market – Overview of key forces propelling and restraining market …
Vulva cancer is rare type of cancer which forms in a woman’s external genitalia called the vulva. The vulva is an area of the skin that surrounds the vagina and urethra, including mons pubis, perineum, labia, bartholin glands, and clitoris. The labia majora is the most common site to develop vulva cancer. The cancer can occur at any age but primarily affects older women over the age of 65 years.
Vulva Cancer Market Dynamics, Segments and Supply Demand 2017 - 2025
Vulva cancer is rare type of cancer which forms in a woman’s external genitalia called the vulva. The vulva is an area of the skin that surrounds the vagina and urethra, including mons pubis, perineum, labia, bartholin glands, and clitoris. The labia majora is the most common site to develop vulva cancer. The cancer can occur at any age but primarily affects older women over the age of 65 years.
Vulva Cancer Market Headed for Growth and Global Expansion by 2025
Vulva cancer is rare type of cancer which forms in a woman’s external genitalia called the vulva. The vulva is an area of the skin that surrounds the vagina and urethra, including mons pubis, perineum, labia, bartholin glands, and clitoris. The labia majora is the most common site to develop vulva cancer. The cancer can occur at any age but primarily affects older women over the age of 65 years.
Vulva Cancer Market Globally Expected to Drive Growth through 2025.
Vulva cancer is rare type of cancer which forms in a woman’s external genitalia called the vulva. The vulva is an area of the skin that surrounds the vagina and urethra, including mons pubis, perineum, labia, bartholin glands, and clitoris. The labia majora is the most common site to develop vulva cancer. The cancer can occur at any age but primarily affects older women over the age of 65 years.
Vulva Cancer Market Scope and Trends Report Upto 2025
Vulva cancer is rare type of cancer which forms in a woman’s external genitalia called the vulva. The vulva is an area of the skin that surrounds the vagina and urethra, including mons pubis, perineum, labia, bartholin glands, and clitoris. The labia majora is the most common site to develop vulva cancer. The cancer can occur at any age but primarily affects older women over the age of 65 years.